Filana Therapeutics, Inc. Stock Analysis & AI Score
Filana Therapeutics, Inc. (FLNA) has an ST Score of 34.4 (C-), driven by its Valuation (B) and held back by its Momentum (D+). FLNA last traded at $0.77.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Filana Therapeutics, Inc. (FLNA) has an ST Score of 34.4 (C-), driven by its Valuation (B) and held back by its Momentum (D+). FLNA last traded at $0.77.
- Strongest
- ValuationB
- Weakest
- MomentumD+
All factor grades
- ValuationB
- ProfitabilityC
- Financial StrengthC
- GrowthC-
- MomentumD+
- Piotroski1/9
Contact
FLNA stock: frequently asked questions
What is FLNA's ST Score?
Filana Therapeutics, Inc. (FLNA) has an ST Score of 34.4 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is FLNA a buy, hold, or sell?
Our ST Score grades it C- (34.4/100). The ST Score is a data-driven signal, not a recommendation.
What are FLNA's factor grades?
Valuation B, Profitability C, Financial Strength C, Momentum D+, Growth C-.
What is FLNA's valuation grade?
Filana Therapeutics, Inc. (FLNA) earns a valuation grade of B, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is FLNA's growth grade?
Filana Therapeutics, Inc. (FLNA) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is FLNA's profitability grade?
Filana Therapeutics, Inc. (FLNA) earns a profitability grade of C, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is FLNA's financial strength grade?
Filana Therapeutics, Inc. (FLNA) earns a financial strength grade of C, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is FLNA's Piotroski score?
Filana Therapeutics, Inc. (FLNA) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.